NEW YORK – Deloitte Consulting announced Monday it has closed on a deal to acquire Recombinant Data Corporation, a Newton, Mass.-based healthcare data warehousing and analytics firm. The move signals the growing momentum toward using clinical data to transform healthcare, say Deloitte officials.
According to Andrew Vaz, principal and chief innovation officer at Deloitte, the move will expand Deloitte’s consulting capabilities.
“We’re definitely already in the analytic and strategic space,” Vaz told Healthcare IT News. “This will expand our interest into the asset space, and we’re very excited about that.”
To read the full, original article click on this link: A sign of the times: Deloitte acquires Recombinant | Healthcare IT News
